Regeneron Pharmaceuticals Inc - REGN - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 12, 2013

Regeneron Pharmaceuticals Inc - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
REGN	Nasdaq	8731	http://www.regeneron.com/	266.97 +2.31
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Regeneron Pharmaceuticals Inc IBD 50 Stocks Delivering Strong Earnings, Sales Gains - May 17th, 2013 4:51 pm Coverage initiated on Regeneron Pharms by UBS - May 17th, 2013 1:21 am A Fundamental, Bottom-Up Approach to Investing in Health Care: Portfolio Manager Finny Kuruvilla Discusses His Strategies with The Wall Street Transcript - May 16th, 2013 1:38 pm Pepper Snapple Group CEO Sells More Than 67K Shares and 4 Insider Sales to Note - May 16th, 2013 7:49 am S&P 500 Stocks Farthest Above 50-DMAs - May 16th, 2013 7:19 am Sanofi and Regeneron's Latest Partnership - May 16th, 2013 6:28 am The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals - May 16th, 2013 5:51 am 4 Healthcare Stock Stories Prescribed for Investors - May 15th, 2013 3:19 pm Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard - May 15th, 2013 3:01 pm Sanofi/REGN Commence Enrollment - May 15th, 2013 3:00 pm 3 Stocks Underperforming Today In The Drugs Industry - May 15th, 2013 11:03 am Cramer: Buy Aqua America, Radian, Regeneron, and These 2 Stocks - May 15th, 2013 10:49 am [video] Cramer's '4 Horsemen of the Apocalypse' for Shorts - May 15th, 2013 7:31 am Sanofi recruits patients for arthritis trials - May 14th, 2013 11:31 pm Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA) - May 14th, 2013 11:00 pm Jim Cramer's 5 Investing Sweet Spots - May 14th, 2013 4:00 pm Why This Stock's Crash is a Buying Opportunity - May 14th, 2013 2:25 pm [video] Cramer's Six in 60: Monster Beverage, Clorox & More - May 14th, 2013 7:52 am [$$] Biotech Fund: Many Healthy Returns - May 14th, 2013 4:10 am Regeneron Pharma raises sales forecast for Eylea - May 3rd, 2013 4:04 pm View All Current Headlines >>